Literature DB >> 24366256

IL-6 mobilizes bone marrow-derived cells to the vascular wall, resulting in neointima formation via inflammatory effects.

Makoto Shoji1, Fumiaki Furuyama, Yuya Yokota, Yasutoshi Omori, Takatoshi Sato, Fumiyoshi Tsunoda, Yoshitaka Iso, Shinji Koba, Eiichi Geshi, Takashi Katagiri, Hiroshi Suzuki, Youichi Kobayashi.   

Abstract

AIM: Among the many factors related to bone marrow cell mobilization, local inflammation induced by cytokines may drive bone marrow cells to the vascular wall, resulting in a thickened neointima. However, the relationship between inflammatory reactions and bone marrow cell invasion has not yet been fully clarified.
METHODS: We inserted a large wire into the femoral artery in male balb/c(WT), interleukin (IL)-6-knockout (KO) and bone marrow-transplanted (BMT) mice that had received bone marrow cells from KO mice. Immunohistochemistry was performed to evaluate the degree of intimal hyperplasia and inflammation following vascular injury.
RESULTS: Three days after the vascular injury, the number of CD34/Sca-1-positive cells in the blood was higher in the KO mice. The numbers of apoptotic cells in the neointima was lower in the KO and BMT mice at two hours after injury. The morphometric analysis performed at one and four weeks after injury showed that the intima/media ratio was significantly lower in the KO and BMT mice, while CD34-positive cells were much more frequent in the WT mice. Furthermore, re-endothelialization appeared earlier in the KO and BMT mice than in the WT mice. No differences in the levels of vascular endothelial growth factor or hepatocyte growth factor were observed in the mice sera between the WT, KO and BMT mice after injury. The in vitro culture of bone marrow cells showed more differentiated smooth muscle-like cells in the WT mice than in the KO mice.
CONCLUSIONS: IL-6 is involved in neointimal formation following vascular injury, possibly acting through inflammatory effects inducing the production of bone marrow cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366256     DOI: 10.5551/jat.19414

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  9 in total

1.  Hydroxysafflor yellow A inhibits lipopolysaccharide-induced proliferation and migration of vascular smooth muscle cells via Toll-like receptor-4 pathway.

Authors:  Guoshuai Yang; Xiaoyan Zhou; Tao Chen; Yidong Deng; Dan Yu; Suyue Pan; Yanmin Song
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Intracranial atherosclerosis: correlation between in-vivo 3T high resolution MRI and pathology.

Authors:  Tanya N Turan; Zoran Rumboldt; Ann-Charlotte Granholm; Laura Columbo; Cynthia T Welsh; Maria F Lopes-Virella; M Vittoria Spampinato; Truman R Brown
Journal:  Atherosclerosis       Date:  2014-10-17       Impact factor: 5.162

3.  Preventive Effect and Mechanism of Crossostephium chinense Extract on Balloon Angioplasty-Induced Neointimal Hyperplasia.

Authors:  Chun-Hsu Pan; Yu-Pei Lin; Jie-Yu Wang; Hui-Yu Huang; Shun-Cheng Huang; Ji-Mehng Lo; Chieh-Hsi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

Review 4.  The future of EPAC-targeted therapies: agonism versus antagonism.

Authors:  Euan Parnell; Timothy M Palmer; Stephen J Yarwood
Journal:  Trends Pharmacol Sci       Date:  2015-03-03       Impact factor: 14.819

5.  Preoperative factors predicting saphenous vein graft occlusion in coronary artery bypass grafting: a multivariate analysis.

Authors:  Agnieszka Malinska; Zuzanna Podemska; Bartlomiej Perek; Marek Jemielity; Piotr Buczkowski; Malgorzata Grzymislawska; Patrycja Sujka-Kordowska; Michal Nowicki
Journal:  Histochem Cell Biol       Date:  2017-05-06       Impact factor: 4.304

Review 6.  Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature.

Authors:  Sean P Didion
Journal:  Int J Mol Sci       Date:  2017-11-29       Impact factor: 5.923

7.  The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs).

Authors:  Jolanta Wiejak; Boy van Basten; Urszula Luchowska-Stańska; Graham Hamilton; Stephen J Yarwood
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-11-09       Impact factor: 4.739

8.  Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistula.

Authors:  Seran Hakki; Emily J Robinson; Michael G Robson
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

9.  The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development.

Authors:  Rob C M de Jong; Mark M Ewing; Margreet R de Vries; Jacco C Karper; Antonius J N M Bastiaansen; Hendrika A B Peters; Fabiana Baghana; Peter J van den Elsen; Céline Gongora; J Wouter Jukema; Paul H A Quax
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.